Besides SjD, the FDA has granted FTD to nipocalimab in three other indications, hemolytic disease of the fetus and newborn (“HDFN”) and warm autoimmune hemolytic anemia (wAIHA), generalized ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback